🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if vortioxetine is better than pla...
Status
Terminated
Location
Alliance for Research
Start Date
2021-08-10
Trial ID
NCT05014919
Treatments Being Tested
The purpose of this study is to evaluate the bioequivalence of a single ora...
Status
Completed
Location
Nishi Kumamoto Hospital
Start Date
2018-02-16
Trial ID
NCT03437564
Treatments Being Tested
This study evaluates the effectiveness of vortioxetine on depressive sympto...
Status
Completed
Location
Marienthali Kliinik (EE0001)
Start Date
2019-12-27
Trial ID
NCT04220996
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of Lu AA2100...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01395147
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of vortioxetine, once...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01163266
Treatments Being Tested
Evaluation of the long-term safety and tolerability of vortioxetine in chil...
Status
Completed
Location
MHAT "Targovishte" AD
Start Date
2017-03-01
Trial ID
NCT03108625
Treatments Being Tested
The objective of the study is to evaluate the pharmacokinetics of vortioxet...
Status
Completed
Location
US003
Start Date
2012-04
Trial ID
NCT01491035
Treatments Being Tested
To explore a neurophysiological marker (electroencephalography) of cognitiv...
Status
Completed
Location
FR801
Start Date
2014-02
Trial ID
NCT02072278
Treatments Being Tested
This study aims at evaluating the effect of vortioxetine on cognitive dysfu...
Status
Completed
Location
FI005
Start Date
2014-12
Trial ID
NCT02272517
Treatments Being Tested
The purpose of this study is to evaluate the gastro-intestinal tolerability...
Status
Completed
Location
GB801
Start Date
2014-04
Trial ID
NCT02112903